Paxlovid treats COVID-19 in adults who do not require supplemental oxygen and who are at an increased risk of progression to severe disease.
Theresa Ha Doan, PharmD Candidate
Advertisement
Articles by Theresa Ha Doan, PharmD Candidate
Advertisement
Latest Updated Articles
Clinical Overview: Paxlovid for COVID-19Published: June 16th 2022 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Poherdy, First Biosimilar to Perjeta, For HER2 Breast Cancer Indications
2
Study Finds Similar Outcomes Between hMPV and RSV Hospitalizations
3
Late-Breaking Data Support Lorundrostat Treatment in Patients With CKD
4
Higher Ultra-Processed Food Intake Linked to Increased Prediabetes Risk in Young Adults
5
